New Drug Approvals

Saperconazole February 20, 2016 - (0)

Saperconazole CAS 110588-57-3 4-[4-[4-[4-[[2-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one (±)-1-sec-butyl-4-[p-[4-[p-[[(2R*,4S*)-2-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-D2-1,2,4-triazolin-5-one 2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-difluorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one R-66905 MF: C35H38F2N8O4 MW: 672.72 Percent Composition: C 62.49%, H 5.69%, F 5.65%, N 16.66%, O 9.51% Properties: Crystals from acetonitrile, mp 189.5°. Poorly sol in water. Melting point: mp 189.5° Therap-Cat: Antifungal. Janssen Pharmacuetica N.V. PHASE 2 Systemic fungal diseases (systemic mycoses) are typically chronic conditions that develop […]
Saroglitazar, Lipaglyn by Zydus Cadila February 18, 2016 - (0)
Zydus Cadila’s, Lipaglyn (Saroglitazar) won a lot of support at the 75th Anniversary Conference of the American Diabetes Association February 18, 2016 - (1)
Should Equipment Status Identification Labels be retained with the Batch Record? February 18, 2016 - (0)
Selurampanel, BGG 492 February 17, 2016 - (0)

Mobile Site | Full Site